The risk of febrile neutropenia in breast cancer patients following adjuvant chemotherapy is predicted by the time course of interleukin‐6 and C‐reactive protein by modelling
Ida Netterberg; Mats O. Karlsson; Elisabet I. Nielsen; Angelica L. Quartino; Henrik Lindman; Lena E. Friberg
Author Information: Department of Pharmaceutical Biosciences
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.